The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 9,341,039 | 563,392 | SH | SOLE | 563,392 | 0 | 0 | |||
| CELSIUS HLDGS INC | COM NEW | 15118V207 | 7,996,372 | 86,038 | SH | SOLE | 86,038 | 0 | 0 | |||
| ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 216,258,934 | 3,192,485 | SH | SOLE | 3,192,485 | 0 | 0 | |||
| FAZE HOLDINGS INC | COMMON STOCK | 31423J102 | 1,437,794 | 3,126,319 | SH | SOLE | 3,126,319 | 0 | 0 | |||
| HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 5,530,451 | 50,673 | SH | SOLE | 50,673 | 0 | 0 | |||
| IDAHO STRATEGIC RESOURCES | COM NEW | 645827205 | 1,323,164 | 271,697 | SH | SOLE | 271,697 | 0 | 0 | |||
| LILLY ELI & CO | COM | 532457108 | 9,272,340 | 27,000 | SH | SOLE | 27,000 | 0 | 0 | |||
| NOVO-NORDISK A S | ADR | 670100205 | 9,405,174 | 59,100 | SH | SOLE | 59,100 | 0 | 0 | |||